300511 Shanghai Xuerong Bio-Technology
- 4.49
- -0.26-5.47%
Shanghai Xuerong Bio-Technology News
Shanghai Xuerong Bio-Technology: Shanghai Xuerong Bio-Technology Co., Ltd.'s 2024 tracking rating report
Shanghai Xuerong Bio-Technology: Announcement of Shanghai Xuerong Biotechnology Co., Ltd. on cumulative new loans exceeding 20% of net assets at the end of the previous year
Xuerong Biology: Shanghai Xuerong Biotechnology Co., Ltd. 2023 Annual Tracking Rating Report
Xuerong Biotech: Announcement by Shanghai Xuerong Biotechnology Co., Ltd. on the results of the resale of Xuerong bonds
Xuerong Biotech: Shanghai Xuerong Biotechnology Co., Ltd.'s third indicative announcement on the resale of Xuerong bonds
Xuerong Biotech: Shanghai Xuerong Biotechnology Co., Ltd.'s second indicative announcement on the resale of Xuerong debt-for-money
Xuerong Biotech: Shanghai Xuerong Biotechnology Co., Ltd.'s first indicative announcement on the resale of Xuerong bonds
Xuerong Biotech: Announcement of Resolutions of the First Bondholders' Meeting of Shanghai Xuerong Biotechnology Co., Ltd. in 2022
Xuerong Biotech: Notice from Shanghai Xuerong Biotechnology Co., Ltd. on holding the first meeting of bond holders in 2022
Xuerong Biotech: Announcement by Shanghai Xuerong Biotechnology Co., Ltd. on interest payments on convertible corporate bonds in 2022
Xuerong Biotech: Announcement by Shanghai Xuerong Biotechnology Co., Ltd. on interest payments on convertible corporate bonds in 2021
Xuerong Biotech: Shanghai Xuerong Biotechnology Co., Ltd. publicly issued convertible corporate bonds tracking rating report (2021)
Xuerong Biotech: 3-3 Listing Sponsorship Letter (Application Draft)
Xuerong Biotech: 2. Response of Ernst & Young Huaming Certified Public Accountants (Special General Partnership) on the Shenzhen Stock Exchange's “Audit Inquiry Letter on Shanghai Xuerong Biotechnology Co., Ltd.'s Application for Issuance of Shares to Spec
Xuerong Biology: 1-1 Application Instructions (Application Draft)
Xuerong Biotech: Supplementary Legal Opinion from Attorney Guohao (Shanghai) Firm on Shanghai Xuerong Biotechnology Co., Ltd.'s 2020 GEM Stock Issuance to Specific Targets (2)
Xuerong Biotech: 3-1 Securities Issuance Sponsorship Letter (Application Draft)
Xuerong Biotech: 1. Comments from Shanghai Xuerong Biotechnology Co., Ltd. and Anxin Securities Co., Ltd. on the review inquiry letter of Shanghai Xuerong Biotechnology Co., Ltd.'s application to issue shares to specific targets (revised draft)
Xuerong Biotech: Audit inquiry letter on Shanghai Xuerong Biotechnology Co., Ltd.'s application to issue shares to specific targets
Xuerong Biotech: 6-1 The issuer's financial report for the most recent year and its audit report and the most recent financial report (for the most recent financial report, please submit the recently announced financial report) (Report)
No Data
